Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 31, 2023

Efficacy and Safety of ICIs Plus Chemotherapy as First-Line Treatment for Extensive-Stage SCLC

Lung Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Lung Cancer
Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis
Lung Cancer 2023 Feb 04;[EPub Ahead of Print], S Wang, Y Li, Z Liu, W Tian, Y Zeng, J Liu, S Zhang, Y Peng, F Wu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading